Press release
Endometrial Cancer Treatment Market :The greatest challenges in the coming year
Overview-Endometrial cancer is the malignancy that develops in the layers of the cells that form the endometrium, the lining of the uterus. Women with high blood pressure, diabetes, or breast cancer are at a greater risk of being affected by endometrial cancer. It usually affect women post menopause, and the risk increases above the age of 40. Surgical procedure, chemotherapy, immunotherapy, targeted therapy, and brachytherapy are the treatment method of Endometrial Cancer. The global Endometrial Cancer Treatment Market is estimated to value over US$ 12.4 billion by 2027.
Drivers-
Endometrial cancer is one of the most prominently observed cancers in women. According to Cancer Organisation, Cancer is among the leading causes of death worldwide. In 2018, there were 18.1 million new cases and 9.5 million cancer-related deaths worldwide. This leads to the growth of the Endometrial Cancer Treatment Market. In addition, new drug development and commercialization further contribute to the growth of this market.
Request for Exclusive sample report here https://www.worldwidemarketreports.com/sample/476543
Restraints-
Treatment of Endometrial Cancer is expensive. This restricts the growth of the Endometrial Cancer Treatment Market
Regional Insights-
North America is expected to dominate the global endometrial cancer market. This can be majorly attributed to increasing prevalence rates of endometrial cancers. For instance, according to Centers for Disease Control and Prevention, in 2017, there were an estimated 793,846 women living with uterine cancer in the United States. In addition, rising awareness for the diagnosis of cancer and the presence of the developed healthcare infrastructure are expected to propel the market in this region.
Competitive Section-
Some of the major players of the market are Bristol-Myers Squibb Company, Pfizer Inc., R-Pharm-US LLC, Elekta AB, and Varian Medical Systems, Inc.
In May 2017, Merck&Co. Inc. received approval from the US FDA for pembrolizumab, to treat tumors with specific genetic diseases including endometrial cancer
In August 2018, Merck&Co. Inc collaborated with Eisai Co. and received approval from the US FDA to combine Lenvatinib for the treatment of patients with Endometrial Cancer
If you have any questions on this report, please reach out to us @ https://www.worldwidemarketreports.com/quiry/476543
Contact Us:
Mr. Shah
Worldwide Market Reports
Seattle, WA 98154,
U.S.
Email: sales@worldwidemarketreports.com
Worldwide Market Reports provides customized upon request. This report can be personalized to suit your needs. Please contact the research team to ensure you receive the report that fits your needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Endometrial Cancer Treatment Market :The greatest challenges in the coming year here
News-ID: 2205472 • Views: …
More Releases from worldwidemarketreports
What are the different trends in Cash Logistics Market to boost its growth?
WorldwideMarket Reports has announced the addition of the “Cash Logistics Market to 2026”, the report classifies the global Cash Logistics Market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth
This report studies the global Cash Logistics market, analyzes and researches the Cash Logistics development status and forecast in United States, EU, Japan, China, India and…
Robo-Taxi Market is expected to register a modest increase in the near-term asse …
A robotaxi also known as a self-driving taxi or a driverless taxi, is an autonomous car (SAE automation level 4 or 5) operated for a ridesharing company . The fact of eliminating the need for a human driver or chauffeur, which represents a significant part of the operating costs of that type of services, could make it a very affordable solution for the customers and accelerate the spreading of Transportation-as-a-Service…
Life Support Systems Market Expected to Beat Earnings Estimates
A life-support system is the combination of equipment that allows survival in an environment or situation that would not support that life in its absence. It is generally applied to systems supporting human life in situations where the outside environment is hostile, such as in space or underwater, or medical situations where the health of the person is compromised to the extent that the risk of death would be high…
Why 2021's ketone market has made young investors ‘excessively optimistic
In chemistry, a ketone is a functional group with the structure R2C=O, where R can be a variety of carbon-containing substituents. Ketones contain a carbonyl group (a carbon-oxygen double bond). The simplest ketone is acetone (R = R' = methyl), with the formula CH3C(O)CH3. Many ketones are of great importance in industry and in biology. Examples include many sugars (ketoses), many steroids (e.g., testosterone), and the solvent acetone.
The ketone…
More Releases for Endometrial
Endometrial Biopsy Catheter Market 2022 | Detailed Report
Global Endometrial Biopsy Catheter Market 2022-2028, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5389813
The report provides…
Endometrial Ablation Market Future Outlook 2021-2030
The Global Endometrial Ablation Market size is estimated to be USD 0.97 billion in 2019 and is predicted to reach USD 1.71 billion by 2030 with a CAGR of 5.3% from 2020-2030.
Endometrial Ablation is a procedure which involves the removal of endometrium, the outer layer of uterus to treat the excessive blood flow during It is one of the mostly used non invasive procedure to treat uterine bleeding, prolong…
Endometrial Biopsy Catheter Market Technological Breakthroughs
Perimenopausal and postmenopausal (absence of menstruation for 12 months or longer) women usually come across problems of abnormal uterine bleeding. Endometrial biopsy is a safe and efficient procedure for sampling the endometrium in a patient experiencing abnormal uterine bleeding to diagnose the condition and provide appropriate treatment. An endometrial suction catheter is used to carry out the biopsy. Endometrial biopsy catheters are easy to use, and have diagnostic accuracy which…
Endometrial Ablation Market Growth Analysis 2024
TMR estimates that the global market for endometrial ablation will exhibit a promising CAGR of 5.50% from 2016 to 2024, rising from an opportunity worth US$0.8 bn in 2015 to US$1.3 bn by 2024.
Rising Rate of Incidence of Gynecological Diseases to Drive Market
The market is expected to benefit from a number of factors, which will be seen in its steady growth path over the course of the report’s forecast. The…
Endometrial Ablation Market snapshot 2024
Global Endometrial Ablation Market: Snapshot
With the rising prevalence of gynecology disorders, such as polycystic ovarian disease (PCOD), abnormal vaginal bleeding, the global adoption of endometrial ablation procedures has increased significantly, leading to an impressive rise in the worldwide endometrial ablation market. Apart from this, the upswing in the incidence rate of cervical and endometrial cancer in women is also driving the growth of this market substantially across the world.
Download The…
Global Endometrial Ablation Market: Radiofrequency Endometrial Ablation Devices …
With the presence of large players, such as Hologic Corp., Boston Scientific Corp., Cooper Surgical Inc., Ethicon Inc., and Medtronic Plc at the global level, the worldwide market for endometrial ablation demonstrates a highly competitive landscape, finds a new research report by Transparency Market Research (TMR).
The market players are focusing aggressively on developing their offerings technologically, which is likely to lead to price differentiation, resulting in intense rivalry between these…
